Federal funding backs engineering to advance the wireless and radio-frequency systems for the wearable toward manufacturing at scale, in partnership with the University of ArizonaContinue reading
Author Archive: AZBio
Precision Epigenomics Named an AZBio Fast Lane Company
Detecting Cancer Before It Starts: How One Arizona Startup Is Transforming Precision Oncology
In modern medicine, early cancer detection remains a central goal. Identifying a tumor before symptoms emerge often makes the difference between routine intervention and a terminal diagnosis.
Standing at the leading edge of this shift is Precision Epigenomics, a Tucson-based bioscience startup whose rapid trajectory over the past 18 months is drawing national attention. Through cutting-edge liquid biopsy technology, rigorous laboratory standards, and high-impact strategic partnerships, the company is turning complex epigenetic science into life-saving clinical tools.Continue reading
Evidence Matters: Navigating the 2026–2027 Respiratory Virus Season
As Arizona enters another respiratory virus season, physicians will once again navigate patient questions surrounding influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) immunization. In an environment of evolving recommendations and competing information, access to rigorous, transparent evidence is essential to informed clinical decision-making.Continue reading
AZBio offers ASU tuition scholarships to Member employees and dependents
Employees of AZBio Member Companies and their dependents can now get a 15% scholarship for over 400 undergraduate degrees, graduate degrees, and certificates offered by ASU Online.
Learn more at AZBio.org/InStrideContinue reading
Bright Path Labs Moves into the Fast Lane
Bright Path is Transforming America’s Access to Essential Medicines..
Bright Path will be honored with an AZBio Fast Lane Award on Oct. 7, 2026 at the Phoenix Convention Center at the 23 annual AZBio Awards.Continue reading
Mayor Gallego Celebrates Flinn Foundation’s Legacy of Leadership and Philanthropy
Global Philanthropy Leadership Award recognizes an enduring commitment to strengthening Arizona and investing in its futureContinue reading
ALIS Acquires Ella® and elbi® Technologies, Expanding AI-Powered Dementia and Behavioral Care Support for Senior Living
Acquisition puts a dementia expert in every caregiver’s pocket to help reduce high-risk behavioral incidents and reliance on psychotropic medicationsContinue reading
AZBioPEERS: Public Policy for the Health Innovation Founder
Public policy decisions can directly influence how health innovations are funded, regulated, reimbursed, adopted, and accessed by patients. This AZBioPEERS video features a discussion hosted by Joan Koerber-Walker, AZBio CEO, with Steve Potts, CEO of Breakthru Medicine, and Tom Eisiminger, Jr., President and CEO of Regenesis Medical, on why policy engagement matters for health innovation entrepreneurs. Panelists will share perspectives on how founders and CEOs can stay informed, build relationships, and make their voices heard on issues that affect company growth, patient access, and Arizona’s broader life science ecosystemContinue reading
Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer’s disease assessment across primary and specialty care
- First and only FDA-cleared, single-biomarker blood test supporting both rule-in and rule-out assessment of amyloid pathology across primary and specialty care settings
- The test delivers consistency across clinical settings by using the same validated cutoffs in primary and specialty care
- Designed for broad implementation across Roche’s installed base of more than 4,500 cobas laboratory instruments in the U.S. supporting access through existing laboratory infrastructureContinue reading
Your Feedback Wanted on Proposed Changes to Reporting Peer Review Outcomes for Applications
NIH is seeking public comment on proposed changes to the reporting of peer review outcomes for grant applications (NOT-OD-26-088). Comments will be accepted electronically here until October 13, 2026.
These proposed updates are intended to strengthen alignment with the NIH Unified Funding Strategy which prioritizes scientific merit and reinforces the central role of peer review in NIH funding decisions. Under this framework, NIH Institutes, Centers, and Offices (ICOs) should consider peer review information in its entirety.Continue reading